Financial burden of drugs prescribed for management of atrial fibrillation

Heart Rhythm. 2023 Oct;20(10):1466-1467. doi: 10.1016/j.hrthm.2023.07.060. Epub 2023 Jul 20.

Authors

Aakash R Sheth¹, Sahith Reddy Thotamgari², Udhayvir Singh Grewal³, Anuj Thakre², Paari Dominic⁴

Affiliations

¹ Department of Cardiology, UPMC Harrisburg, Harrisburg, Pennsylvania.
² Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana.
³ Department of Hematology Oncology, University of Iowa, Iowa City, Iowa.
⁴ Department of Cardiology, University of Iowa, Iowa City, Iowa. Electronic address: [email protected].

PMID: 37481221
DOI: 10.1016/j.hrthm.2023.07.060

No abstract available

Keywords: Atrial fibrillation; DOAC; Financial burden; Generic formulation; Prescription drugs; Uninsured.

Publication types

Letter

MeSH terms

Administration, Oral
Anticoagulants / therapeutic use
Atrial Fibrillation* / drug therapy
Financial Stress
Humans
Retrospective Studies
Stroke*
Warfarin / therapeutic use

Substances

Anticoagulants
Warfarin